Initial medwatch submitted to the fda on 13/oct/2020 a review of the device labeling notes the following: the current overstitch¿ endoscopic suturing system (ess) instructions for use (ifu) addressed the known and potential event of "other-clinical outcome device related" as follows: warnings: only physicians possessing sufficient skill and experience in similar or the same techniques should perform endoscopic procedures.Ensure that there is sufficient space for the needle to open.Warning: do not introduce the device with the needle body in its open position.Adverse event: possible complications that may result from using the endoscopic suturing system include, but may not be limited to: -nausea and / or vomiting -abdominal pain and / or bloating -pharyngeal, colonic and/or esophageal perforation the labeling is adequate as it addresses the reported complaints.The occurrence of this reported complaint for this product will be reviewed as appropriate in the complaints analysis meeting (cam).
|